Skip to search formSkip to main contentSkip to account menu

hepatitis immune

Known as: immune hepatitis 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
IgG subclass profile among anti‐Glutathione S‐transferase T1 antibodies in post‐transplant de novo immune hepatitis
Although the pathogenic pathways leading to de novo immune hepatitis (IH) are not completely understood, we have shown strong… 
2012
2012
Comments on Anagnostis et al.: De novo autoimmune hepatitis associated with PTH(1–34) and PTH(1–84) administration for severe osteoporosis in a liver transplant patient
Dear Editor,In their recent paper, Anagnostis et al. [1] described a rarecase of association of parathyroid hormone (PTH) 1–34… 
2011
2011
Choice of calcineurin inhibitor may influence the development of de novo immune hepatitis associated with anti‐GSTT1 antibodies after liver transplantation
Aguilera I, Sousa JM, Praena JM, Gómez‐Bravo MA, Núñez‐Roldan A. Choice of calcineurin inhibitor may influence the development of… 
2007
2007
Antibodies against glutathione S-transferase T1 (GSTT1) in patients with GSTT1 null genotype as prognostic marker: long-term follow-up after liver transplantation.
An objective to improve the evolution of transplants is to identify risk biomarkers of morbidity and loss of allograft. In liver… 
2005
2005
Glutathione S-transferase T1 genetic mismatch is a risk factor for de novo immune hepatitis in liver transplantation.
Highly Cited
2004
Highly Cited
2004
Glutathione S‐transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation
A new form of autoimmune hepatitis referred to as de novo, has been reported after liver transplantation during the past 5 years… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)